BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 29644993)

  • 1. Apparent Diffusion Coefficient to Subdivide Breast Imaging Reporting and Data System Magnetic Resonance Imaging (BI-RADS-MRI) Category 4 Lesions.
    Liu D; Ba Z; Ni X; Wang L; Yu D; Ma X
    Med Sci Monit; 2018 Apr; 24():2180-2188. PubMed ID: 29644993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adding a Model-free Diffusion MRI Marker to BI-RADS Assessment Improves Specificity for Diagnosing Breast Lesions.
    Goto M; Le Bihan D; Yoshida M; Sakai K; Yamada K
    Radiology; 2019 Jul; 292(1):84-93. PubMed ID: 31112086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcategorization of Suspicious Breast Lesions (BI-RADS Category 4) According to MRI Criteria: Role of Dynamic Contrast-Enhanced and Diffusion-Weighted Imaging.
    Maltez de Almeida JR; Gomes AB; Barros TP; Fahel PE; de Seixas Rocha M
    AJR Am J Roentgenol; 2015 Jul; 205(1):222-31. PubMed ID: 26102403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Value of Lesion Size as an Adjunct to the BI-RADS-MRI 2013 Descriptors in the Diagnosis of Solitary Breast Masses.
    Kawai M; Kataoka M; Kanao S; Iima M; Onishi N; Ohashi A; Sakaguchi R; Toi M; Togashi K
    Magn Reson Med Sci; 2018 Jul; 17(3):203-210. PubMed ID: 29213007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining b2500 diffusion-weighted imaging with BI-RADS improves the specificity of breast MRI.
    Saccenti L; Mellon CM; Scholer M; Jolibois Z; Stemmer A; Weiland E; de Bazelaire C
    Diagn Interv Imaging; 2023 Sep; 104(9):410-418. PubMed ID: 37208291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mean Apparent Diffusion Coefficient Is a Sufficient Conventional Diffusion-weighted MRI Metric to Improve Breast MRI Diagnostic Performance: Results from the ECOG-ACRIN Cancer Research Group A6702 Diffusion Imaging Trial.
    McDonald ES; Romanoff J; Rahbar H; Kitsch AE; Harvey SM; Whisenant JG; Yankeelov TE; Moy L; DeMartini WB; Dogan BE; Yang WT; Wang LC; Joe BN; Wilmes LJ; Hylton NM; Oh KY; Tudorica LA; Neal CH; Malyarenko DI; Comstock CE; Schnall MD; Chenevert TL; Partridge SC
    Radiology; 2021 Jan; 298(1):60-70. PubMed ID: 33201788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion tensor imaging for characterizing tumor microstructure and improving diagnostic performance on breast MRI: a prospective observational study.
    Luo J; Hippe DS; Rahbar H; Parsian S; Rendi MH; Partridge SC
    Breast Cancer Res; 2019 Sep; 21(1):102. PubMed ID: 31484577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent diffusion coefficient (ADC) value to evaluate BI-RADS 4 breast lesions: correlation with pathological findings.
    Ramírez-Galván YA; Cardona-Huerta S; Ibarra-Fombona E; Elizondo-Riojas G
    Clin Imaging; 2015; 39(1):51-5. PubMed ID: 25457520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Combined Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MRI for Differentiating Malignant From Benign Breast Lesions Presenting Washout Curve.
    Tezcan S; Ozturk FU; Uslu N; Akcay EY
    Can Assoc Radiol J; 2021 Aug; 72(3):460-469. PubMed ID: 32157892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.
    Imamura T; Isomoto I; Sueyoshi E; Yano H; Uga T; Abe K; Hayashi T; Honda S; Yamaguchi T; Uetani M
    Magn Reson Med Sci; 2010; 9(4):217-25. PubMed ID: 21187691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of a breast apparent diffusion coefficient category system (ADC-B) derived from a large multicenter MRI database.
    Bickel H; Clauser P; Pinker K; Helbich T; Biondic I; Brkljacic B; Dietzel M; Ivanac G; Krug B; Moschetta M; Neuhaus V; Preidler K; Baltzer P
    Eur Radiol; 2023 Aug; 33(8):5400-5410. PubMed ID: 37166495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted imaging (b value = 1500 s/mm(2)) is useful to decrease false-positive breast cancer cases due to fibrocystic changes.
    Ochi M; Kuroiwa T; Sunami S; Murakami J; Miyahara S; Nagaie T; Oya M; Yabuuchi H; Hatakenaka M
    Breast Cancer; 2013 Apr; 20(2):137-44. PubMed ID: 22161277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Problem Solving MRI to Reduce False-Positive Biopsy Related to Breast US: Conductivity vs. DWI vs. Abbreviated Contrast-Enhanced MRI.
    Kim JH; Kim SY; Cui C; Ji H; Yoen H; Cho N; Kim DH
    J Magn Reson Imaging; 2024 Apr; 59(4):1218-1228. PubMed ID: 37477575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of observation size and apparent diffusion coefficient (ADC) value in PI-RADS v2.1 assessment category 4 and 5 observations compared to adverse pathological outcomes.
    Abreu-Gomez J; Walker D; Alotaibi T; McInnes MDF; Flood TA; Schieda N
    Eur Radiol; 2020 Aug; 30(8):4251-4261. PubMed ID: 32211965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the "Breast Imaging Reporting and Data System" for multiparametric 3-T imaging of breast lesions.
    Pinker K; Bickel H; Helbich TH; Gruber S; Dubsky P; Pluschnig U; Rudas M; Bago-Horvath Z; Weber M; Trattnig S; Bogner W
    Eur Radiol; 2013 Jul; 23(7):1791-802. PubMed ID: 23504036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scoring system based on BI-RADS lexicon to predict probability of malignancy in suspicious microcalcifications.
    Youk JH; Son EJ; Kim JA; Moon HJ; Kim MJ; Choi CH; Kim EK
    Ann Surg Oncol; 2012 May; 19(5):1491-8. PubMed ID: 22173328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of Synthetic Relaxometry and Diffusion Measures in the Differentiation of Benign and Malignant Breast Lesions as Compared to BI-RADS.
    Gao W; Zhang S; Guo J; Wei X; Li X; Diao Y; Huang W; Yao Y; Shang A; Zhang Y; Yang Q; Chen X
    J Magn Reson Imaging; 2021 Apr; 53(4):1118-1127. PubMed ID: 33179809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative DWI implemented after DCE-MRI yields increased specificity for BI-RADS 3 and 4 breast lesions.
    Dijkstra H; Dorrius MD; Wielema M; Pijnappel RM; Oudkerk M; Sijens PE
    J Magn Reson Imaging; 2016 Dec; 44(6):1642-1649. PubMed ID: 27273694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grading System to Categorize Breast MRI in BI-RADS 5th Edition: A Multivariate Study of Breast Mass Descriptors in Terms of Probability of Malignancy.
    Fujiwara K; Yamada T; Kanemaki Y; Okamoto S; Kojima Y; Tsugawa K; Nakajima Y
    AJR Am J Roentgenol; 2018 Mar; 210(3):W118-W127. PubMed ID: 29381382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value for malignancy of suspicious breast masses of BI-RADS categories 4 and 5 using ultrasound elastography and MR diffusion-weighted imaging.
    Satake H; Nishio A; Ikeda M; Ishigaki S; Shimamoto K; Hirano M; Naganawa S
    AJR Am J Roentgenol; 2011 Jan; 196(1):202-9. PubMed ID: 21178068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.